ASPRV1
Retroviral-like aspartic protease 1
Also known as: APRV1_HUMAN, FLJ25084, SASPase, Taps
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53RT3
- Gene
- ASPRV1
- Ensembl
- ENSG00000244617
- Chromosome
- 2
- Canonical length
- 343 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Filaggrin is a structural protein that is crucial for in the development and maintenance of the skin barrier. This gene encodes a retroviral-like protease involved in profilaggrin-to-filaggrin processing. Expression is found primarily in the epidermis and inner root sheath of hair follicles. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
343 residues, UniProt reviewed canonical sequence.
>Q53RT3|ASPRV1
1 MGSPGASLGI KKALQSEQAT ALPASAPAVS QPTAPAPSCL PKAGQVIPTL LREAPFSSVI
61 APTLLCGFLF LAWVAAEVPE ESSRMAGSGA RSEEGRRQHA FVPEPFDGAN VVPNLWLHSF
121 EVINDLNHWD HITKLRFLKE SLRGEALGVY NRLSPQDQGD YGTVKEALLK AFGVPGAAPS
181 HLPKEIVFAN SMGKGYYLKG KIGKVPVRFL VDSGAQVSVV HPNLWEEVTD GDLDTLQPFE
241 NVVKVANGAE MKILGVWDTA VSLGKLKLKA QFLVANASAE EAIIGTDVLQ DHNAILDFEH
301 RTCTLKGKKF RLLPVGGSLE DEFDLELIEE DPSSEEGRQE LSHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASPRV1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 615 nTPM
Expression across tissuesHPA
Tissue
- skin: 615 nTPM
- cervix: 24 nTPM
- breast: 24 nTPM
- spinal cord: 7.5 nTPM
- midbrain: 5.3 nTPM
- skeletal muscle: 4.9 nTPM
Single-cell type
- oligodendrocytes: 4.4 nCPM
- oligodendrocyte progenitor cells: 3.4 nCPM
- astrocytes: 2.8 nCPM
- bergmann glia: 1.8 nCPM
- podocytes: 1.8 nCPM
- ependymal cells: 1.7 nCPM
Immune cell
- neutrophil: 11 nTPM
- eosinophil: 2.1 nTPM
- plasmacytoid DC: 1 nTPM
- T-reg: 0.8 nTPM
- gdT-cell: 0.5 nTPM
- MAIT T-cell: 0.5 nTPM
Brain region
- white matter: 17 nTPM
- medulla oblongata: 12 nTPM
- basal ganglia: 12 nTPM
- midbrain: 11 nTPM
- cerebral cortex: 10 nTPM
- thalamus: 9.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ASPRV1.
Disease | AllUniProt
Conditions ASPRV1 is implicated in, by any mechanism.
- Ichthyosis, lamellar, autosomal dominant (ADLI) MIM:146750
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 62 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant lamellar ichthyosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aspartic peptidase, active site
- Peptidase A2A, retrovirus, catalytic
- Aspartic peptidase domain superfamily
- Retroviral-like aspartic protease 1
- gag-polyprotein putative aspartyl protease
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASPRV1 as an antibody target. Whether an autoantibody or antibody against ASPRV1 could matter depends on whether native ASPRV1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASPRV1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASPRV1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...